Clients with Hepatic Impairment Ritalin hasn't been examined in people with hepatic impairment. Hepatic impairment is expected to acquire negligible impact on the pharmacokinetics of methylphenidate as it is metabolized primarily to ritalinic acid by nonmicrosomal hydrolytic esterases which migh